19185-89-8Relevant articles and documents
HYDROXYL PURINE COMPOUNDS AND USE THEREOF
-
Paragraph 0164; 0165; 0166, (2018/06/09)
Disclosed are a series of hydroxyl purine compounds and the use thereof as PDE2 or TNFα inhibitors, in particular, the compounds as shown in formula (I), or tautomers or pharmaceutically acceptable salts thereof.
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 26-27, (2012/08/28)
The present disclosure relates to compounds of formula I, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in th
INHIBITORS OF SERINE PROTEASES
-
Page/Page column 303, (2010/11/26)
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.